1. Home
  2. BLIN vs GTBP Comparison

BLIN vs GTBP Comparison

Compare BLIN & GTBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridgeline Digital Inc.

BLIN

Bridgeline Digital Inc.

N/A

Current Price

$0.87

Market Cap

12.1M

Sector

Technology

ML Signal

N/A

Logo GT Biopharma Inc.

GTBP

GT Biopharma Inc.

N/A

Current Price

$7.49

Market Cap

13.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BLIN
GTBP
Founded
2000
1965
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.1M
13.0M
IPO Year
2018
2016

Fundamental Metrics

Financial Performance
Metric
BLIN
GTBP
Price
$0.87
$7.49
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$4.62
N/A
AVG Volume (30 Days)
28.8K
350.3K
Earning Date
05-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.75
EPS
N/A
N/A
Revenue
$13,568,000.00
N/A
Revenue This Year
$22.67
N/A
Revenue Next Year
$21.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.69
$0.22
52 Week High
$1.59
$8.82

Technical Indicators

Market Signals
Indicator
BLIN
GTBP
Relative Strength Index (RSI) 26.04 70.84
Support Level $0.82 $0.36
Resistance Level $0.87 N/A
Average True Range (ATR) 0.05 0.91
MACD -0.00 0.89
Stochastic Oscillator 5.77 66.49

Price Performance

Historical Comparison
BLIN
GTBP

About BLIN Bridgeline Digital Inc.

Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing therapeutics from its proprietary product platform across various disease areas, mainly focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platform offers immuno-oncology products designed to treat hematologic malignancies, sarcoma, and solid tumors.

Share on Social Networks: